재발성-이장성 다발성 경화증 환자의 재발빈도 감소성인에 대한 권장용량은 글라티라머아세테이트 40mg(이 약 1 프리필드시린지)을 최소 48시간의 간격으로 1주 3회 피하주사 한다. 이 약의 투여는 신경과전문의 또는...
Glatiramer acetate Clinical data Trade names Copaxone, [1] Glatopa, [2] Brabio AHFS /Drugs.... Subcutaneous injection ATC code L03AX13 (WHO ) Legal status Legal status AU : S4 (Prescription...
of copaxone used for the treatment of multiple sclerosis. In the latter case, an injection may produce a small dent at the injection site.[1] Lipoatrophy occurs in HIV-associated...
Instruct patients in proper injection technique and to rotate injection sites (5.3) • COPAXONE can modify immune response (5.4) • Hepatic Injury: if signs or symptoms of hepatic...
2. Qualitative and quantitative composition ; 1 pre-filled syringe (1 ml) of solution for injection contains 20 mg glatiramer acetate*, equivalent to 18 mg of glatiramer. Glatiramer acetate is the acetate salt of synthetic polypeptides, containing four naturally occurring amino acids: L-glutamic acid, L-alanine, L-tyrosine and L-lysine, in molar fraction ranges of 0.129-0.153, 0.392-0.462, 0.086-0.100 and 0.300-0.374, respectively. The average molecular weight of glatiramer acetate is in the range of 5,000-9,000 daltons. Due to its compositiona ...
I, the patient administers insulin by inhalation rather than by subcutaneous injection. Ai에 따라서, 환자는 인슐린을 피하 주사가 아닌 흡입에 의해서 투여한다.
COPAXONE® (glatiramer acetate injection) has provided treatment & resources for those with relapsing MS since 1996. See use, prescribing information, and more.
Specifically, Copaxone can be used to treat the following conditions: Clinically isolated syndrome (CIS). With CIS, you have an episode of MS-like symptoms that lasts at least 24 hours. CIS may or may not develop into MS. Relapsing-remitting MS (RRMS). With RRMS, you have periods when your MS symptoms relapse (flare up) followed by periods when your MS symptoms are in remission (improved or have gone away). Active secondary progressive MS (SPMS). With active SPMS, the condition steadily becomes worse, but you still have periods of relapse. Duri ...
HIGHLIGHTS OF PRESCRIBING INFORMATION ; 2 DOSAGE AND ADMINISTRATION ; 5 WARNINGS AND PRECAUTIONS ; 6 ADVERSE REACTIONS ; 7 DRUG INTERACTIONS ; 8 USE IN SPECIFIC POPULATIONS ; 13 NONCLINICAL TOXICOLOGY ; 14 CLINICAL STUDIES ; Package/Label Display Panel, 20 mg/mL ; Package/Label Display Panel,40 mg/mL
Copaxone ; Generic Name: glatiramer acetate · Brand Name: Copaxone · Drug Class: IMMUNOMODULATORS